Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer
Clinical trial NCT03162731 · COMPLETED
Trial details
- NCT number
- NCT03162731
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-11
- Primary completion
- 2020-09-27
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.